The progression of cancer is remarkable for its ability to evade the immune system. SPOCK1 plays crucial roles in lung carcinoma malignant phenotypes and CD8â+âT cell infiltration. Here, we looked at how SPOCK1 drives immune evasion in lung cancer and unraveled the underlying mechanisms. Expression analyses were performed using quantitative PCR (qPCR), immunoblotting, or immunohistochemistry (IHC). Cell proliferation and viability were assessed by MTT assay. Cell apoptosis, invasion, and sphere formation were evaluated. The POU2F1-SPOCK1 relationship was analyzed by luciferase and ChIP assays. The ELAVL1-SPOCK1 relationship was verified by SPOCK1 mRNA stability analysis. In vivo validation of the POU2F1-SPOCK1 axis was performed using xenograft assays along with lentiviral rescue approach. Increased levels of SPOCK1 predicted poor clinical outcomes in lung carcinoma patients (nâ=â39) and were associated with PDL1 expression and the tumor mutational burden (TMB). SPOCK1 depletion suppressed the growth, invasion, and stemness of lung cancer cells. Moreover, SPOCK1 depletion increased TNF-α and IFN-γ secretion, enhanced CD8â+âT cell viability, and suppressed CD8â+âT cell apoptosis in vitro. Mechanistically, POU2F1 transcriptionally controlled SPOCK1 expression. SPOCK1 restoration reversed the impact of POU2F1 depletion on cancer cell malignant phenotypes and tumor immune evasion. Furthermore, ELAVL1 increased SPOCK1 mRNA stability to upregulate SPOCK1. Additionally, SPOCK1 increase rescued the growth of POU2F1-depleted A549 xenografts in vivo (nâ=â5 per group). Our findings demonstrate that SPOCK1 upregulation induced by POU2F1 or ELAVL1 contributes to lung carcinoma progression by sustaining cancer cell malignant phenotypes and promoting immune evasion, suggesting SPOCK1 as a potential target for lung cancer therapy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10616-025-00804-9.
The oncogenic role of SPOCK1 in lung carcinoma by promoting immune evasion and its related mechanisms.
SPOCK1通过促进免疫逃逸在肺癌中发挥致癌作用及其相关机制
阅读:4
作者:Lv Geni, Chen Juan, Wei Dan, Zhang Wenzhe, Xie Wanhui, Yang Shuanying
| 期刊: | Cytotechnology | 影响因子: | 1.700 |
| 时间: | 2025 | 起止号: | 2025 Aug;77(4):138 |
| doi: | 10.1007/s10616-025-00804-9 | 研究方向: | 免疫/内分泌 |
| 疾病类型: | 肺癌 | ||
特别声明
1、本文转载旨在传播信息,不代表本网站观点,亦不对其内容的真实性承担责任。
2、其他媒体、网站或个人若从本网站转载使用,必须保留本网站注明的“来源”,并自行承担包括版权在内的相关法律责任。
3、如作者不希望本文被转载,或需洽谈转载稿费等事宜,请及时与本网站联系。
4、此外,如需投稿,也可通过邮箱info@biocloudy.com与我们取得联系。
